Comparison of two drugs combination for post operative pain relief in adenotonsillectomy in children

Peritonsillar infiltration with bupivacaine and dexamethasone versus ropivacaine and dexamethasone for post operative pain relief in adenotonsillectomy: A comparative study in children - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062175

Enrollment

Registered

2024-02-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J351- Hypertrophy of tonsils Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: LOCAL INFILTRATION: LOCAL INFILTRATION OF DRUGS IN ANTERIOR PILLAR OF TONSIL Control Intervention1: Comparision of peritonsillar infiltration with local anaesthetic drugs for post opera

Eligibility

Inclusion criteria

Inclusion criteria: ASA PS 1 and 2, Planned for adenotonsillectomy, Age 2 to 12 years

Exclusion criteria

Exclusion criteria: Patient refusal, ASA PS >2, Allergy, Signs of acute pharyngeal infection, Peritonsillar abscess, Bleeding disorder, Use of regular analgesic medication

Design outcomes

Primary

Measure	Time frame
To compare the effect of peritonsillar infiltration with bupivacaine and dexamethasone versus ropivacaine and dexamethasone for post operative pain relief in adenotonsillectomy in children inrelation to: 1. Duration of post operative analgesia. 2. Total dose of rescue analgesia in the first 24 hours postoperatively. Timepoint: 24 hours	—

Secondary

Measure	Time frame
To observe the haemodynamic parameters, To observe any post operative complication Timepoint: 24hrs	—

Countries

India

Contacts

Public ContactDr Anita Pareek

Sardar Patel Medical College, Bikaner, Rajasthan

dranitapareek23@gmail.com9828101281

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026